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S224 Poster Session Iassessed.VIP-KOmice,WTlittermates, and recipientswere infected
with 5 104 PFU murine cytomegalovirus (mCMV) and T cell re-
sponse to viral antigen was measured by flow cytometry for mCMV
peptide-MHC class I-tetramer+ CD8+ T-cells at day 0, 3, 7, 10, and
day 15 post infection or 80, 83, 87 and 101 days post-transplant (in-
fection at day 80 post-transplant). Day 15 post mCMV challenge,
VIP-KO andWTmice were euthanized. DC and T-cells were puri-
fied from BM and SP by FACS andMACS, respectively. 2 105/mL
DC treated with 1 104 PFU mCMV peptide-expressing Listeria-
CMV construct and incubated with 2 106/mL T-cells at 37 C.
Cultured 3 days and 7 days, cells were harvested and analyzed with
DC and T-cell surface marker, tetramer, and intracellular cytokines
by flow cytometry.
Results: allogeneic recipients of VIP-KO BM and VIP-KO SP de-
veloped more GvHD than recipients of WT grafts using a lower
dose of donor SP (1 106), while there was no difference in survival.
The GvHD scores and the percentage of survival showed no differ-
ence among other syngeneic or allogeneic BMT settings.The spe-
cific anti-viral immunity was similar among the non-transplanted
VIP-KO mice, and allogeneic and syngeneic transplant recipients
of VIP-KO donor cells. 3 and 7 days post culture, VIP-KO DC ex-
pressed higher-level of CD80, MHC-II and lower-level of PD-L1,
VIP-KOT-cells had higher-level of tetramer+ CD8+ T-cells and in-
tracellular IFN-g, lower-level of IL-4 and IL-5, PD1, and ICOS.
Taken together, these observations suggest that VIP expressed on
immune cells suppresses anti-viral immune responses and Th1 po-
larization.
Conclusion: The anti-viral immune responses of VIP-KO immune
cells were independent allogeneic immunity; VIP expressed by neu-
rocrine cells inWT recipients did not compensate for the lack of VIP
in mice transplanted with VIP-KO cells. Modulation of the VIP
pathway is a novel method to regulate post-transplant immunity al-
logeneic transplant recipients.178
THE LIVER MAINTAINS STRONG POPULATIONS OF INNATE IMMUNE
CELLS THAT CONTRIBUTE TO HOST PROTECTION AFTER ALLOGENEIC
HEMATOPOIETIC CELL TRANSPLANTATION
Mueller, A.M.S.1,2, Tran, P.1, Shizuru, J.A.1 1Stanford School of Med-
icine, Stanford, CA; 2University Medical Center, Freiburg i.Br., Ger-
many
The liver is a critical immunocompetent organ armed with lym-
phocytes, natural killer (NK) cells, and a variety of antigen-present-
ing cells (APC), including resident macrophages, called Kupffer cells
(KC). Exposed to large amounts of both destructive and harmless
toxins and antigens, the liver must provide immunogenic and tolero-
genic immunity. Here, we studied the role of the liver after hemato-
poietic cell transplantation (HCT). Lethally irradiated BALB.K
mice received MHC-matched, purified hematopoietic stem cells
(HSC; cKit + Sca1 + Thy1.1loLin-) +/- splenocytes (SP) from
AKR/J donors. Ficoll-separated mononuclear cells (MNC) from
PBS flushed livers were FACS analyzed post-HCT (pTX). In recip-
ients ofHSC + SP the liver was amajor target organ of acute graft-vs-
host disease (GVHD) with prominent donor T cell (TC) expansion,
while NK cell (DX5 + CD122+) and KC (CD11b + F4/80+) levels
were severely decreased. HSC-derived donor cells were rare. In con-
trast, mice given pure HSC showed no signs of GVHD, and early
pTX high proportions of NK cells and KC were present within
the livers. NK cells comprised up to 30% of cells and were mixed
donor/host type, while KC were donor derived at 6w pTX. We hy-
pothesized that rapid regeneration of KC may shield against the
pathogen and toxin load entering the circulation from irradiation-
damaged intestines. In fact, when KC reconstitution was suppressed
by silica administration mice displayed severe weight loss, hunched
posture, ruffled fur, diarrhea, and a .50% mortality. Survivors sta-
bilized d12, presumably with gut recovery. To test if regenerating
APC could protect against GVHD, a lethal dose of SP was given at 0,
4, 7, or 10d pTX, time points at which control livers contained 0, 11,
25, 32% KC, respectively. All mice receiving SP on d0 died, but
death occurred in only 50%, 17% and 0% of mice when SP were
given on d4, 7, and 10, respectively. Although donor chimerism de-
creased with delayed SP injection, lymphocyte reconstitution wasimproved. In conclusion, the role of the liver as an immunologically
active organ after ‘conventional’ HCT is often masked by donor TC
expansion and GVHD. Rapid recovery of innate liver immunity may
protect the host from endotoxemia and mediate tolerance between
donor and host. Elevated proportions of NK cells, which are lacking
in GVHD affected mice suggest another beneficial mechanism. Im-
munohistochemical studies for a better quantitative assessment of
resident liver immune cells are underway.179
A TREND FOR BETTER IMMUNE RECONSTITUTION AND LOWER INCI-
DENCE OF INFECTIONS AFTER UNRELATED CORD BLOOD TRANSPLAN-
TATION IN CHILDREN COMPARED TO ADULTS
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In umbilical cord blood transplantation (UCBT), the lower in-
fused cell dose might lead to an increased infectious risk. To get fur-
ther insights on this issue, we retrospectively analyzed infectious
events and immune restoration in 35 consecutive patients (pts)
treated by UCBT from Jan 2005 to Dec 2008 in the University Hos-
pital of Besanc¸on.
There were 7 children and 28 adults aged 6 to 62 y (median 35y).
All pts suffered frommalignant diseases. Nine pts were in CR1, 10 in
CR2 and 16 in$CR3 or in PR.Nine pts were CMV+ and 29EBV+. A
myeloablative conditioning regimen with 12 GY TBI (16pts) or Bu-
sulfan (2 pts) + 120 mg/kg cyclophosphamide + 75 mg/m2 fludara-
bine was given to 18 pts, one child received ALG instead of
fludarabine. A fludarabine based reduced intensity conditioning
(RIC) was given to 17 pts. There were 29 double and 6 single unit
transplants. The median follow-up is 638 days (259-1449).
All pts engrafted except 3 after RIC. Fifteen pts died (43%), 10 of
relapse, 4 of infection (1 ARDS,1 zygomycosis, 1 fusariosis and 1
HHV6 encephalitis) and 1 died of post-conditioning toxicity. There
were 8 infectious events in 7 children, (mean 1.14/pt) with 1 death in
the pt who received ALG and 86 infectious events in 28 adults (mean
3.07/pt) causing 3 deaths.
Viral infections occurred in 27 pts (77%) in majority before D100
(73%). BKV+ hemorrhagic cystitis (HC) occurred in 13 pts, VZV (6),
CMV (5), HHV6 (1), HSV (1), and RSV (1). We recorded 22 docu-
mented bacterial infections caused by 13 Gram negative and 9 Gram
positive agents. Invasive fungal infections were diagnosed in 9 pts
(26%) with 6 proven or probable aspergillosis, 2 fungal septicaemias
and 1 zygomycosis. Fungal infections seemed more frequent in pts
experiencing chronic GVHD (35% versus 21.4%, hazard ra-
tio5 1.6, p5 0.91).
The immune reconstitution appeared quicker in children, the me-
dian CD4 T cell count at 3-6-12 months post UCBTwas 224-1008-
1333/mm3 in children and 119-216-364 in adults. Median B cell
count at 6 mo post UCBT was 868 in children versus 106 in adults.
Among the 20 survivors at 1 year post transplant, the vaccine re-
sponse was complete in 15 pts, incomplete in 2, non available in 3.
The lower incidence of infectious events in children might be due
to a better immune reconstitution. The overall infectious mortality
rate is relatively low (11%). The high prevalence of HC advocates
for a prospective follow-up of BK virus and the high rate of Zoster
warrants preventive strategies.LATE EFFECTS/QUALITY OF LIFE
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A PROSPECTIVE STUDY OF IRON-OVERLOAD (IO) MANAGEMENT IN AL-
LOGENEIC HEMATOPOIETIC-CELL TRANSPLANT (ALLO HCT) SURVIVORS
Majhail, N.S.1, Lazarus, H.M.2, Burns, L.J.1 1University of Minnesota,
Minneapolis, MN; 2Case Western Reserve University, Cleveland, OH
While transfusional IO occurs in 30-60% of allo HCT survi-
vors, the treatment of post-HCT IO is not well described. We
Poster Session I S225report the results of a single-center, prospective evaluation for IO
and its subsequent treatment in 147 allo HCT survivors. Adult
(.18 years) allo HCT recipients were eligible for this study if
(1) they had survived for $1 year post-HCT, (2) were in remis-
sion from their primary disease, (3) had no uncontrolled infection
or GVHD, (4) had no contraindication for MRI, (5) had ade-
quate blood counts and renal and hepatic function, and (6) had
significant IO. Patients were screened with serum ferritin, and
those with ferritin .1000 ng/mL underwent liver R2 MRI to es-
timate liver iron concentration (LIC, normal #1.8 mg/g). Signif-
icant IO was defined as LIC $5 mg/g. Based on physician and
patient preference, patients with significant IO were offered ob-
servation only, phlebotomy, or were enrolled on a pilot study
of deferasirox (if phlebotomy was not feasible [hemoglobin
\11 g/dL] or was refused). 23 patients had IO (LIC .1.8) and
16 had significant IO (LIC $5). Among patients with significant
IO, 69% had acute leukemia and 56% had received myeloabla-
tive conditioning. The median baseline LIC was 10.0 (range,
5.1-43). All patients were transfusion independent at enrollment.
Five patients received no treatment (median LIC 6.4), 8 under-
went phlebotomy (median LIC 13.1) and 3 received daily defer-
asirox 20 mg/kg/day for 6 months (median LIC 6.3). Two
patients had abnormal liver function tests and one patient each
had cirrhosis and unexplained heart failure; all four received
phlebotomy. Followup serum ferritin decreased spontaneously
in 4 patients on the observation arm (median ferritin, 1606 at
baseline to 1264 at followup); 1 also had followup MRI (LIC de-
creased from 6.4 to 2.3). Phlebotomy was well tolerated and no
patient needed ESA’s to facilitate phlebotomy. Deferasirox was
well tolerated and led to a decrease in LIC in all 3 patients
(baseline to 6 mo LIC: 6.3 to 2.8, 9.0 to 6.8, 19.9 to 8.8).
Mild adverse events were observed that did not require discontin-
uation of drug therapy. Phlebotomy is feasible in the majority of
allo HCT recipients who have survived for $1 year after HCT
and have significant IO. Iron levels may decrease with time with-
out any therapy in selected allo HCT survivors. Although the
numbers are small, deferasirox may be a safe and effective alter-
native for allo HCT survivors with IO who cannot undergo phle-
botomy.181
CLINICAL RELEVANCE OF LARGE GRANULAR LYMPHOCYTE EXPANSION
FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTA-
TION WITH HLA IDENTICAL SIBLING DONORS
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Galal, A.1, Gupta, V.1, Kuruvilla, J.1, Lipton, J.H.1, Messner, H.A.1
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Background:Large granular lymphocytes (LGLs) are amorpholog-
ically distinct but an immunophenotypically heterogeneous set of
lymphocytes of activated T- orNK cells that mediate non-MHC-re-
stricted cytotoxicity. LGL expansion following allogeneic hemato-
poietic stem cell transplantation (HSCT) has been reported
although its clinical relevance on transplant outcomes is not clear.
Moreover, precipitating factor evoking LGL expansion is unknown.
Methods: A total of 323 consecutive patients who received alloge-
neic HSCTs from HLA identical sibling donors between January
2000 andOctober 2007 at the PrincessMargaret Hospital, Toronto,
Canada, were included in the retrospective study. The patients’ char-
acteristics were: gender (male/female5 196/127); median age 49.5
yrs (range 17-71); stem cell source (PBSC/BM5 25172); condition-
ing (myeloablative/reduced intensity5 228/95). The definition of
LGL expansion is as follows: 1) increasing number of peripheral
blood lymphocyte counts$ 3.0109/L for at least 3 months, and
2) the predominance of LGLs in the peripheral blood smears.
Results: Out of 323 recipients, 64 cases (19.8%) showed LGL ex-
pansion after allogeneic hematopoietic stem cell transplantation
(HSCT). The median onset of LGL expansion was 306 days (95%C.I. 205-407 days). The 1- and 2-year(s) incidence of LGL expan-
sion was 14.46 2.2% and 22.06 2.8%.
Compared to the patients without LGL expansion, improved
transplant outcomes were observed in patients with LGL expan-
sion: better overall survival (2 years OS; 94.8% vs 60.3%,
p\0.001), lower non-relapse mortality (2 years NRM; 2.6% vs
23.4%, p\0.001) and lower relapse incidence (5.6% vs 29.5%,
p\0.001).
Three risk factors were identified for the development of LGL ex-
pansion such as CMV serostatus of recipient, CMV reactivation, and
occurrence of chronic GVHD. Higher incidence of LGL expansion
was noted 1) in recipient CMV IgG (+) group (CMV-R+) compared
to CMV-R- group regardless of CMV serostatus of donor (52/193
[27%] vs 11/128 [9%]; p\0.001); 2) in patients experiencing
CMV reactivation (43/140 [31%] vs 21/183 [11%]; p\0.001); 3)
in patients developing chronic GVHD (61/252 [24%] vs 2/55
[4%]; p5 0.02).
Conclusion: LGL expansion is not uncommon following alloge-
neic HSCT with HLA-identical sibling donors, and strongly as-
sociates with favorable transplant outcomes esp. in terms of non-
relapse mortality. Its association with chronic GVHD suggested
that expanded LGLs may mediate GVL effect after allogeneic
HSCT.182
PERIPHERAL AIRWAY FUNCTION DECLINES FOLLOWING ALLOGENEIC
TRANSPLANTATION AND IS ASSOCIATED WITH THE DEVELOPMENT OF
CHRONIC GVHD
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Bronchiolits Obliterans (BO) is the most frequent non-infec-
tious pulmonary complication post allogeneic stem cell transplant
(SCT) and is strongly correlated with cGVHD. BO remains
a major cause of late post SCT morbidity and mortality. Airflow
obstruction as detected by spirometry occurs late in BO, only
when widespread small airways disease is well established and
the process is more likely to be irreversible. The Multiple Breath
Nitrogen Washout (MBNW) test is a sensitive and reproducible
measure of peripheral airway function that is highly sensitive to
bronchiolitis in smokers with otherwise normal spirometry. Its
role in assessing peripheral airway dysfunction and early BO
post SCT has not been assessed. In a cross sectional study, 30
pts post SCT (mean age 47, 19-68 yrs) underwent standard spi-
rometric and lung volume testing together with measurements of
acinar (Sacin) and conductive (Scond) peripheral airway ventila-
tory heterogeneity and Lung Clearance Index (LCI) as assessed
by MBNW. Median time post SCT was 12 (3-73) mths, with
most pts receiving reduced intensity conditioning (17/30) for
acute leukemia (15/30). 50% had prior aGVHD, though no pts
had active aGVHD at the time of testing. 20/30 pts had
cGVHD, with 18 pts having active disease at the time of testing.
40% had moderate/severe cGVHD by NIH Consensus Criteria.
27% cohort had evidence of airway obstruction (FEV1/FVC
\70% predicted), while abnormal Sacin (.0.3L21) and Scond
(.0.04L21) affected 73% and 80% respectively. Sacin, Scond
and LCI were inversely correlated to FEV1% predicted while
Scond and LCI were correlated with RV/TLC% predicted. 1
pt with evidence of obstruction had normal Sacin, while 13 pts
with normal spirometry had abnormal Sacin. On univariate anal-
ysis, poorer FEV1/FVC%, Sacin, Scond and LCI measures were
strongly associated with days post transplant, but only Sacin
(p5 0.016) and Scond (p5 0.014) were significantly associated
with a diagnosis of cGVHD. Poorer Sacin was also correlated
with increasing severity of cGVHD (R25 0.48, p5 0.002). On
multivariate analysis only cGVHD (p5 0.01) remained an inde-
pendent predictor of abnormal Sacin. Peripheral airway function
appears to decline following SCT, and is strongly associated with
the development of cGVHD. Prospective studies are being
